No. Biological products are not eligible for the exemptions for compounded drugs under sections 503A and 503B of the Federal Food, Drug, and Cosmetic (FD&C) Act. Federal law does not provide a legal pathway for marketing biologics that have been prepared outside the scope of an approved biologics license application.